| MR编号 | DE/V/0021/001 |
|---|
| 药品名称 | Rispoval IBR-Marker inactivatum |
|---|
| 活性成分 | - bovine herpesvirus inactivated 2.0 ml
|
|---|
| 剂型 | Suspension for injection |
|---|
| 上市许可持有人 | Zoetis Deutschland GmbH
Schellingstr. 1
10785 Berlin |
|---|
| 参考成员国 - 产品名称 | Germany (DE) |
|---|
| 互认成员国 - 产品名称 | - Belgium (BE)
Rispoval IBR-Marker inactivatum - Netherlands (NL)
Bayovac IBR-Marker inactivatum - Luxembourg (LU)
Bayovac IBR-Marker inactivatum - United Kingdom (Northern Ireland) (XI)
Bayovac IBR-Marker inactivatum - Ireland (IE)
Bayovac IBR-Marker inactivatum - Spain (ES)
Bayovac IBR-Marker inactivatum - Italy (IT)
Bayovac IBR-Marker inactivatum - Portugal (PT)
- Poland (PL)
- Latvia (LV)
Rispoval IBR-Marker Vivum - Lithuania (LT)
- Estonia (EE)
- Hungary (HU)
- Czechia (CZ)
- Romania (RO)
- Slovakia (SK)
- Slovenia (SI)
- Malta (MT)
|
|---|
| 许可日期 | 2008/04/05 |
|---|
| 最近更新日期 | 2024/09/24 |
|---|
| 药物ATC编码 | - QI02A CATTLE
- QI02 IMMUNOLOGICALS FOR BOVIDAE
- QI IMMUNOLOGICALS
- QI02AA03 bovine rhinotracheitis virus (IBR)
- QI02AA Inactivated viral vaccines
| 申请类型 | - TypeLevel1：[not specified]
- TypeLevel2：[not specified]
- TypeLevel3：Full Dossier (art.5)
- TypeLevel4：[not specified]
- TypeLevel5：[not specified]
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|